Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael C Wehr

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Molecular Biology and Evolution|April 1, 2014
Evolutionary and molecular facts link the WWC protein family to Hippo signalingDirk Oliver Wennmann, Jürgen Schmitz, Michael C Wehr, et al.
Cells|January 21, 2022
Expression of Lineage Transcription Factors Identifies Differences in Transition States of Induced Human Oligodendrocyte DifferentiationFlorian J Raabe, Marius Stephan, Jan Benedikt Waldeck, et al.
EMBO Molecular Medicine|July 27, 2017
Spironolactone is an antagonist of NRG1-ERBB4 signaling and schizophrenia-relevant endophenotypes in miceMichael C Wehr, Wilko Hinrichs, Magdalena M Brzózka, et al.
Contemporary Clinical Trials Communications|February 20, 2020
Add-on spironolactone as antagonist of the NRG1-ERBB4 signaling pathway for the treatment of schizophrenia: Study design and methodology of a multicenter randomized, placebo-controlled trialAlkomiet Hasan, Astrid Roeh, Stefan Leucht, et al.
Cell Reports|December 8, 2022
Hippo-released WWC1 facilitates AMPA receptor regulatory complexes for hippocampal learningJens Stepan, Daniel E Heinz, Frederik Dethloff, et al.
Communications Medicine|June 16, 2026
Antagonizing NRG1-ERBB4 signaling pathway with spironolactone for the treatment of schizophrenia: results of a randomized controlled drug repositioning clinical trialAlkomiet Hasan, Stefan Leucht, Astrid Roeh, et al.
Science Signaling|April 30, 2024
Inhibiting Hippo pathway kinases releases WWC1 to promote AMPAR-dependent synaptic plasticity and long-term memory in miceJens Stepan, Daniel E Heinz, Frederik Dethloff, et al.
Biorxiv : the Preprint Server for Biology|January 23, 2024
Polygenic risk for schizophrenia converges on alternative polyadenylation as molecular mechanism underlying synaptic impairmentFlorian J Raabe, Anna Hausruckinger, Miriam Gagliardi, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Molecular Biology and Evolution|April 1, 2014
Evolutionary and molecular facts link the WWC protein family to Hippo signalingDirk Oliver Wennmann, Jürgen Schmitz, Michael C Wehr, et al.
Cells|January 21, 2022
Expression of Lineage Transcription Factors Identifies Differences in Transition States of Induced Human Oligodendrocyte DifferentiationFlorian J Raabe, Marius Stephan, Jan Benedikt Waldeck, et al.
EMBO Molecular Medicine|July 27, 2017
Spironolactone is an antagonist of NRG1-ERBB4 signaling and schizophrenia-relevant endophenotypes in miceMichael C Wehr, Wilko Hinrichs, Magdalena M Brzózka, et al.
Contemporary Clinical Trials Communications|February 20, 2020
Add-on spironolactone as antagonist of the NRG1-ERBB4 signaling pathway for the treatment of schizophrenia: Study design and methodology of a multicenter randomized, placebo-controlled trialAlkomiet Hasan, Astrid Roeh, Stefan Leucht, et al.
Cell Reports|December 8, 2022
Hippo-released WWC1 facilitates AMPA receptor regulatory complexes for hippocampal learningJens Stepan, Daniel E Heinz, Frederik Dethloff, et al.
Communications Medicine|June 16, 2026
Antagonizing NRG1-ERBB4 signaling pathway with spironolactone for the treatment of schizophrenia: results of a randomized controlled drug repositioning clinical trialAlkomiet Hasan, Stefan Leucht, Astrid Roeh, et al.
Science Signaling|April 30, 2024
Inhibiting Hippo pathway kinases releases WWC1 to promote AMPAR-dependent synaptic plasticity and long-term memory in miceJens Stepan, Daniel E Heinz, Frederik Dethloff, et al.
Biorxiv : the Preprint Server for Biology|January 23, 2024
Polygenic risk for schizophrenia converges on alternative polyadenylation as molecular mechanism underlying synaptic impairmentFlorian J Raabe, Anna Hausruckinger, Miriam Gagliardi, et al.
Pageof 4